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Parkinson’s Disease (PD), the second most frequent
neurodegenerative disorder after Alzheimer’s disease
(six million patients world-wide), is generally diagnosed
after the sixth decade. It causes motor dysfunctions,
such as bradykinesia, resting tremor, rigidity and pos-
tural instability, but also affects autonomic functions
and cognition. PD results mainly from progressive
degeneration of dopaminergic neurons in the substantia
nigra and other monoaminergic cell groups in the
brainstem, increased microglial activation and accumu-
lation of proteins in surviving dopaminergic neurons,
known as Lewy bodies and Lewy neurites. The etiology
of PD is unknown, although older age and neurotoxins
are established risk factors, and smoking appears to be
protecitive. In the last decade, several causative genes
and susceptibility factors have been identified in rare
families with Mendelian inheritance, and suggest that
abnormal handling of misfolded proteins by the ubiqui-
tin-proteosome and authophagy-lysosomal systems,
increased oxidative stress, mitochondrial and lysosomal
dysfunctions, and other pathogenic dysfunctions, contri-
bute to PD. Although PD was long considered a non
genetic disorder of sporadic origin, 5-10% of patients
are now known to have monogenic forms of the disease.
At least, 13 loci and 9 genes are associated with both
autosomal dominant (PARK1 and PARK4/alpha-synu-
clein (SNCA); PARK5/UCHL1;PARK8/LRRK2;PARK11/
GIGYF2,PARK13/Omi/Htra2) and autosomal recessive
(PARK2/Parkin; PARK6/PINK1; PARK7/DJ-1;PARK9/
ATP13A2) PD. Monogenic forms represent less than
10% of PD in most populations. The vast majority result
from complex interactions among genes and between
genes and environmental factors. Genetic variations
may be susceptibility factors or disease modifiers, affect-
ing penetrance, age at onset, severity and progression.
High-density arrays of single nucleotide polymorphisms
(SNPs) permit the identification of susceptibility factors
in genome- wide association (GWA) studies, in which
the frequencies of putative risk alleles are compared in
patients and controls. The identification and characteri-
zation of Mendelian forms of PD and association stu-
dies in sporadic PD patients delineating molecular
pathways that are involved in dopaminergic cell dys-
function and death.
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